1. Home
  2. EUDA vs CALC Comparison

EUDA vs CALC Comparison

Compare EUDA & CALC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo EUDA Health Holdings Limited

EUDA

EUDA Health Holdings Limited

HOLD

Current Price

$2.27

Market Cap

68.7M

Sector

Finance

ML Signal

HOLD

Logo CalciMedica Inc.

CALC

CalciMedica Inc.

HOLD

Current Price

$4.63

Market Cap

63.0M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
EUDA
CALC
Founded
2021
2011
Country
Singapore
United States
Employees
N/A
N/A
Industry
Blank Checks
Biotechnology: Pharmaceutical Preparations
Sector
Finance
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
68.7M
63.0M
IPO Year
N/A
N/A

Fundamental Metrics

Financial Performance
Metric
EUDA
CALC
Price
$2.27
$4.63
Analyst Decision
Strong Buy
Analyst Count
0
2
Target Price
N/A
$14.50
AVG Volume (30 Days)
36.8K
106.0K
Earning Date
01-01-0001
11-12-2025
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
0.01
N/A
Revenue
$5,160,280.00
N/A
Revenue This Year
$137.25
N/A
Revenue Next Year
$361.43
N/A
P/E Ratio
$313.71
N/A
Revenue Growth
83.73
N/A
52 Week Low
$1.03
$1.42
52 Week High
$6.30
$4.82

Technical Indicators

Market Signals
Indicator
EUDA
CALC
Relative Strength Index (RSI) 39.34 70.23
Support Level $2.81 $3.65
Resistance Level $3.21 $4.74
Average True Range (ATR) 0.31 0.43
MACD -0.06 0.07
Stochastic Oscillator 3.42 89.81

Price Performance

Historical Comparison
EUDA
CALC

About EUDA EUDA Health Holdings Limited

EUDA Health Holdings Ltd is a non-invasive healthcare company across Southeast Asia and China. The Company has two reportable segments: property management services and holistic wellness consumer products and services. Key revenue is generated from property management services that include common area property management services that contain cleaning, landscaping, public facilities maintenance and other traditional services and also include security property management services provided to all tenants and property owners.

About CALC CalciMedica Inc.

CalciMedica Inc is a clinical-stage biopharmaceutical company focused on developing therapeutics that treat serious illnesses driven by inflammatory and immunologic processes and direct cellular damage. Its product candidates act upon calcium release-activated calcium (CRAC) channels and would constitute a new class of drugs. Its product candidate is Auxora, a potent and selective intravenous formulated small molecule CRAC channel inhibitor containing the active compound zegocractin (formerly referred to as CM4620) that, in animal models, reduced acute epithelial and/or endothelial cell injury and inflammation in organs, such as the pancreas, lungs and kidneys.

Share on Social Networks: